← Leaderboards
Benjamin Hackel
University Of Minnesota
$5,467,295
Attributed
$6,343,997
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $986.5K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,343,997 · 7
By mechanism
R01$5,302,506 · 4
R21$816,491 · 2
R41$225,000 · 1
Top collaborators
- Jonathan N Sachs4 shared
- David Peter Lenzi1 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Mikael H Elias$2,327,122
- Sergio A Gradilone$3,873,849
- Haojie Huang$10,928,769
- Nobuaki Kikyo$6,960,699
- Kristina Astleford-Hopper$246,294
Others in their field
Top investigators on “Engineering”
- David Heimbrook · Leidos Biomedical Research, Inc.$265,348,415
- Francis L Halzen · University Of Wisconsin-Madison$239,306,664
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
- Daniel Stanzione · Arizona State University$173,674,275
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$173,157,760
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
Research focus
EngineeringBindingMolecularProteinsLigandsEvolutionMutantDesignScaffoldBiophysicsVariantLibrariesAffinityProtein EngineeringSpecificityAntibody Binding SitesMolecular ImagingLeadTechnologyHigh Throughput ScreeningTargeted TreatmentDeep SequencingAntibodiesInnovation
Grant awards (21)
Engineering protein developability$338,220
R01 · FY2025 · GM · contact PI
Engineering protein developability$338,220
R01 · FY2024 · GM · contact PI
Engineering protein developability$338,220
R01 · FY2023 · GM · contact PI
Engineering synthetic ligands with potent allosteric inhibition of tumornecrosis factor receptors$443,728
R01 · FY2022 · EB · contact PI
Engineering protein developability$338,220
R01 · FY2022 · GM · contact PI
Engineering synthetic ligands with potent allosteric inhibition of tumornecrosis factor receptors$434,853
R01 · FY2021 · EB · contact PI
Engineering synthetic ligands with potent allosteric inhibition of tumornecrosis factor receptors$380,139
R01 · FY2020 · EB · contact PI
Engineering Gp2 as a small ligand scaffold$319,422
R01 · FY2020 · EB · contact PI
Engineering Antimicrobial Polypeptides against Pathogenic Bacteria$286,945
R01 · FY2020 · GM · contact PI
Engineering Gp2 as a small ligand scaffold$319,546
R01 · FY2019 · EB · contact PI
Engineering Antimicrobial Polypeptides against Pathogenic Bacteria$287,052
R01 · FY2019 · GM · contact PI
Engineering synthetic ligands with potent allosteric inhibition of tumornecrosis factor receptors$269,685
R01 · FY2019 · EB · contact PI
Engineering Gp2 as a small ligand scaffold$319,227
R01 · FY2018 · EB · contact PI
Engineering Antimicrobial Polypeptides against Pathogenic Bacteria$286,303
R01 · FY2018 · GM · contact PI
Engineering Gp2 as a small ligand scaffold$318,030
R01 · FY2017 · EB · contact PI
Engineering Antimicrobial Polypeptides against Pathogenic Bacteria$284,696
R01 · FY2017 · GM · contact PI
Enhanced molecular imaging agents via designed ligand charge$223,431
R21 · FY2017 · EB · contact PI
Small, high-affinity ligands for array tomography$225,000
R41 · FY2016 · MH
Molecular PET Imaging of MET with Small Protein Ligands$223,405
R21 · FY2016 · EB · contact PI
Enhanced molecular imaging agents via designed ligand charge$184,194
R21 · FY2016 · EB · contact PI
Molecular PET Imaging of MET with Small Protein Ligands$185,461
R21 · FY2015 · EB · contact PI